Cargando…
Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets
Ubiquitin–proteasome system (UPS) is a primary signaling pathway for regulation of intracellular protein levels. E3 ubiquitin ligases, substrate-specific members of the UPS, represent highly attractive protein targets for drug discovery. The importance of E3 ligases as prospective targets for small...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951978/ https://www.ncbi.nlm.nih.gov/pubmed/29867461 http://dx.doi.org/10.3389/fphar.2018.00450 |
_version_ | 1783323110927237120 |
---|---|
author | Bulatov, Emil Zagidullin, Almaz Valiullina, Aygul Sayarova, Regina Rizvanov, Albert |
author_facet | Bulatov, Emil Zagidullin, Almaz Valiullina, Aygul Sayarova, Regina Rizvanov, Albert |
author_sort | Bulatov, Emil |
collection | PubMed |
description | Ubiquitin–proteasome system (UPS) is a primary signaling pathway for regulation of intracellular protein levels. E3 ubiquitin ligases, substrate-specific members of the UPS, represent highly attractive protein targets for drug discovery. The importance of E3 ligases as prospective targets for small molecule modulation is reinforced by ever growing evidence of their role in cancer and other diseases. To date the number of potent compounds targeting E3 ligases remains rather low and their rational design constitutes a challenging task. To successfully address this problem one must take into consideration the multi-subunit nature of many E3 ligases that implies multiple druggable pockets and protein–protein interfaces. In this review, we briefly cover the current state of drug discovery in the field of RING-type E3 ligases with focus on MDM and Cullin families as targets. We also provide an overview of small molecule chimeras that induce RING-type E3-mediated proteasomal degradation of substrate proteins of interest. |
format | Online Article Text |
id | pubmed-5951978 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-59519782018-06-04 Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets Bulatov, Emil Zagidullin, Almaz Valiullina, Aygul Sayarova, Regina Rizvanov, Albert Front Pharmacol Pharmacology Ubiquitin–proteasome system (UPS) is a primary signaling pathway for regulation of intracellular protein levels. E3 ubiquitin ligases, substrate-specific members of the UPS, represent highly attractive protein targets for drug discovery. The importance of E3 ligases as prospective targets for small molecule modulation is reinforced by ever growing evidence of their role in cancer and other diseases. To date the number of potent compounds targeting E3 ligases remains rather low and their rational design constitutes a challenging task. To successfully address this problem one must take into consideration the multi-subunit nature of many E3 ligases that implies multiple druggable pockets and protein–protein interfaces. In this review, we briefly cover the current state of drug discovery in the field of RING-type E3 ligases with focus on MDM and Cullin families as targets. We also provide an overview of small molecule chimeras that induce RING-type E3-mediated proteasomal degradation of substrate proteins of interest. Frontiers Media S.A. 2018-05-08 /pmc/articles/PMC5951978/ /pubmed/29867461 http://dx.doi.org/10.3389/fphar.2018.00450 Text en Copyright © 2018 Bulatov, Zagidullin, Valiullina, Sayarova and Rizvanov. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Bulatov, Emil Zagidullin, Almaz Valiullina, Aygul Sayarova, Regina Rizvanov, Albert Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets |
title | Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets |
title_full | Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets |
title_fullStr | Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets |
title_full_unstemmed | Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets |
title_short | Small Molecule Modulators of RING-Type E3 Ligases: MDM and Cullin Families as Targets |
title_sort | small molecule modulators of ring-type e3 ligases: mdm and cullin families as targets |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5951978/ https://www.ncbi.nlm.nih.gov/pubmed/29867461 http://dx.doi.org/10.3389/fphar.2018.00450 |
work_keys_str_mv | AT bulatovemil smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets AT zagidullinalmaz smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets AT valiullinaaygul smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets AT sayarovaregina smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets AT rizvanovalbert smallmoleculemodulatorsofringtypee3ligasesmdmandcullinfamiliesastargets |